Anatomically Selective Serotonergic Type 1A and Serotonergic Type 2A Therapies for Parkinson’s Disease: An Approach to Reducing Dyskinesia without Exacerbating Parkinsonism?

Newsletter

获取来自 Atuka 的最新科学进展

订阅我们的季刊,了解帕金森疾病研究领域的最新进展。

注册清单

Talk to our experts

赋能您的研发项目